<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">The main characteristics of COVID-19, such as leukopenia, thrombocytopenia, myocarditis, and interstitial pneumonia, could also be observed in rheumatic diseases such as SLE and systemic sclerosis [
 <xref ref-type="bibr" rid="CR18">18</xref>, 
 <xref ref-type="bibr" rid="CR70">70</xref>, 
 <xref ref-type="bibr" rid="CR71">71</xref>]. However, the clinically significant features are mainly from the inflammatory characteristics that mimic our diseases in both clinical features and pathogenesis. Having common pathways in the pathogenesis highlights some of the drugs that rheumatologists use as candidates for COVID-19 treatment.
</p>
